Evaluation of therapeutic efficacy of 211At-labeled farletuzumab in an intraperitoneal mouse model of disseminated ovarian cancer.
Transl Oncol
; 14(1): 100873, 2021 Jan.
Article
in En
| MEDLINE
| ID: mdl-32987283
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Transl Oncol
Year:
2021
Document type:
Article
Affiliation country: